Literature DB >> 12789487

[Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron].

Th Stratz1, W Müller.   

Abstract

Local injection of the 5-HT3 receptor antagonist tropisetron manifests a distinct analgesic effect in various local diseases of the locomotor system such as tendinopathies, peri-arthropathies,myofascial pain syndrome, in trigger points, and in inflammatory joint processes.This effect corresponds to that exerted by local anesthetics in general use such as lidocaine and prilocaine among others, but the effect lasts considerably longer. The reason for this finding is found in a simultaneous antiphlogistic effect of the 5-HT3 receptor antagonist as evidenced by animal experiments and clinical data.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789487     DOI: 10.1007/s00482-003-0219-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  5 in total

Review 1.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

Review 2.  [Myofascial pain syndrome].

Authors:  R Forst; A Ingenhorst
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

Review 3.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

4.  The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.

Authors:  Akash Pandhare; Aneesh Satya Pappu; Henrik Wilms; Michael Paul Blanton; Michaela Jansen
Journal:  Neuropharmacology       Date:  2016-09-24       Impact factor: 5.250

Review 5.  Is serotonin hyperalgesic or analgesic?

Authors:  Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2006-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.